WallStreetZenWallStreetZen

NASDAQ: ITOS
Iteos Therapeutics Inc Stock Ownership - Who owns Iteos Therapeutics?

Insider buying vs selling

Have Iteos Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Matthew GallChief Financial Officer2023-10-125,000$8.37
$41.85kBuy
Boxer Capital LLCInsider2023-08-23219,638$16.87
$3.71MSell
Boxer Capital LLCInsider2023-08-2395,516$15.63
$1.49MSell
Boxer Capital LLCInsider2023-08-2334,846$14.19
$494.46kSell

1 of 1

ITOS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ITOS insiders and whales buy or sell their stock.

ITOS Shareholders

What type of owners hold Iteos Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Mpm Bioventures 2018 LP15.83%5,674,086$59.98MInsider
Mpm Bioventures 2014 LP15.83%5,674,086$59.98MInsider
Ansbert Gadicke12.51%4,484,728$47.40MInsider
Ra Capital Management LP12.32%4,417,259$46.69MInstitution
Blackrock Inc11.89%4,261,745$45.05MInstitution
Mpm Asset Management LLC7.64%2,738,785$28.95MInstitution
Aaron I. Davis6.21%2,226,301$23.53MInsider
Boxer Capital LLC5.03%1,804,058$19.07MInsider
Boxer Capital LLC5.03%1,804,058$19.07MInstitution
Mpm Bioimpact LLC4.87%1,745,943$18.45MInstitution

1 of 3

ITOS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ITOS62.37%37.63%Net Selling
ANRO0.00%24.97%Net BuyingNet Buying
LXRX21.34%78.66%Net BuyingNet Buying
FBLG0.00%0.39%
ADPT62.07%37.93%Net SellingNet Selling

Iteos Therapeutics Stock Ownership FAQ

Who owns Iteos Therapeutics?

Iteos Therapeutics (NASDAQ: ITOS) is owned by 97.68% institutional shareholders, 58.93% Iteos Therapeutics insiders, and 0.00% retail investors. Mpm Bioventures 2018 LP is the largest individual Iteos Therapeutics shareholder, owning 5.67M shares representing 15.83% of the company. Mpm Bioventures 2018 LP's Iteos Therapeutics shares are currently valued at $60.15M.

If you're new to stock investing, here's how to buy Iteos Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.